New drug candidate B-OT takes first step in human safety trial
Knowledge-focused
Completed
This early-stage trial tested the safety and tolerability of an experimental drug called Benfo-Oxythiamine (B-OT) in 48 healthy male volunteers. Researchers gave the drug as single or multiple daily doses and monitored participants closely for side effects, blood levels, and lab …
Phase: PHASE1 • Sponsor: Benfovir AG • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC